Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

Healthcare

Beyond Daily Move: What Investors Are Watching Around Mesoblast (ASX:MSB)?

Mesoblast (ASX:MSB) shares closed at AUD 2.40 on 12 August 2026, declining 0.41% during the trading session. The movement occurred during a broader market session where Australian equities recorded declines, with investors continuing to monitor conditions across the healthcare sector.

Aditi Sarkar | 12 August 2026

Neuren Pharmaceuticals (ASX:NEU) Shares Under Pressure as Investors Track the Biotechnology Landscape

Neuren Pharmaceuticals (ASX:NEU) shares closed at AUD 23.31 on 12 August 2026, declining 1.40% during the trading session. The movement occurred during a broader market session where Australian equities recorded declines, with investors continuing to monitor conditions across the healthcare sector.

Aditi Sarkar | 12 August 2026

Alterity Therapeutics Ltd (ASX:ATH): ATH434 Advances Toward Phase 3 Development

The company has reached an important regulatory milestone for ATH434 after receiving a positive outcome from its End-of-Phase 2 meeting with the US Food and Drug Administration (FDA). The regulatory alignment provides a potential pathway toward a single pivotal Phase 3 study for Multiple …

Sonal Goyal | 12 August 2026

EchoIQ (ASX:EIQ): AI-Powered Cardiac Diagnostics and Healthcare Technology

EchoIQ develops AI-based software designed to analyse echocardiograms and assist healthcare professionals in identifying cardiac conditions.

Sonal Goyal | 12 August 2026

INOVIQ (ASX:IIQ): Exosome Diagnostics and Cancer-Testing Development

INOVIQ is focused on developing technologies that use exosomes and other extracellular vesicles for cancer diagnosis, research and potential therapeutic applications.

Sonal Goyal | 12 August 2026

Cryosite (ASX:CTE) Growth Story Draws Attention as Specialist Storage Business Expands

Cryosite (ASX:CTE), a Sydney-based cold-chain logistics and cord-blood banking company, has attracted renewed market attention following improved operating performance and increased investor interest in small-cap healthcare-related businesses. The company has expanded its specialist storage capabilities while maintaining a debt-free balance sheet. Investors are assessing …

Aditi Sarkar | 12 August 2026

Proteomics International (ASX:PIQ) Faces Funding Test as PromarkerD Advances

Proteomics International (ASX:PIQ) sits between scientific progress and a demanding funding position. PromarkerD remains the centrepiece of the diagnostics pipeline, with commercial activity in Australia and California andManufacturingcapacity already established, while other programs such as PromarkerEso and the endometriosis test continue to build clinical …

Aditi Sarkar | 12 August 2026

dorsaVi (ASX:DVL) Takes Next Step Towards AI Memory Platform With Silicon Production Milestone

dorsaVi Ltd (ASX:DVL) was trading at AUD 0.025, up 8.70% during the morning session on 12 August 2026, while remaining down 37.50% over the past year. The company has announced that manufacturing of its first RRAM-CMOS validation chip has commenced, marking the transition of …

Aditi Sarkar | 12 August 2026

Pro Medicus (ASX:PME): New US Health System Contract Highlights Visage 7 Platform Expansion

Pro Medicus Ltd (ASX:PME) was trading at AUD 180.82, down 0.83% during the day, with shares remaining down 40.36% over the past year. The healthcare technology company has announced a new seven-year contract with St. Luke’s Health System in the United States, expanding the …

Aditi Sarkar | 12 August 2026

Austco Healthcare Limited (ASX:AHC) Share Market Overview and Healthcare Sector Profile

Austco Healthcare Limited (ASX:AHC) is an Australian Securities Exchange-listed company operating within the health care equipment and services industry group.

Anjali Anand | 11 August 2026
Support

Hi! How can we help you today?

Loading…